Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody
Author:
Affiliation:
1. School of Pharmaceutical Sciences, Shandong University, 44 Wenhua Xi Road, Ji’nan 250012, China
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/mp200402e
Reference37 articles.
1. A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs
2. Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic Review
3. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide
4. Nanomedicine: current status and future prospects
5. Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives;Journal of Drug Delivery Science and Technology;2024-02
2. Smart nanoparticles for cancer therapy;Signal Transduction and Targeted Therapy;2023-11-03
3. Surface Immobilization of Anti-VEGF Peptide on SPIONs for Antiangiogenic and Targeted Delivery of Paclitaxel in Non-Small-Cell Lung Carcinoma;ACS Applied Bio Materials;2023-06-29
4. Nano-interventions for the drug delivery of docetaxel to cancer cells;Health Sciences Review;2023-06
5. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review;Pharmaceutics;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3